Xenon Pharmaceuticals (XENE)
Develops azetukalner and ion-channel medicines for epilepsy, depression, and pain.
$39.18
After hours+0.10 (+0.27%)
At close$39.08(+0.22%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 101.44% | 98.24M shares | |
|---|---|---|---|
| 325 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 0.10% | 94.8K shares | |
| 10 holders · as of Sep 3, 2026 | |||
| Adds to | 101.54% | ||
96.84M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
These groups come from separate filings that can overlap, so they add to 101.54%; nothing is left for Other.
13F, as of Jun 30, 2026
325 holders · 98.24M shares · 51 new positions · 181 increased · 86 reduced · 25 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 9.65M | 9.96% | −1.17M | Aug 13, 2026 |
| BlackRock, Inc. | 7.52M | 7.77% | +1.88M | Aug 7, 2026 |
| Avoro Capital Advisors LLC | 5.78M | 5.97% | 0 | Aug 14, 2026 |
| Polar Capital Holdings PLC | 4.57M | 4.72% | +165.2K | Aug 14, 2026 |
| Driehaus Capital Management LLC | 4.42M | 4.56% | −73.1K | Aug 14, 2026 |
| Jupiter Topco LLC | 4.19M | 4.32% | +4.19Mnew | Aug 14, 2026 |
| Price T Rowe Associates Inc /MD/ | 3.25M | 3.35% | +1.92M | Aug 14, 2026 |
| JPMorgan Chase & Co | 2.62M | 2.70% | +693.8K | Aug 12, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| FMR LLC | 11.50% | 8.82M | 13G | Aug 6, 2025 |
| Avoro Capital Advisors LLC | 6.26% | 5.78M | 13G | May 15, 2026 |
| Wellington Management Group LLP | 6.20% | 4.76M | 13G | Feb 10, 2026 |
| BlackRock, Inc. | 6.20% | 4.76M | 13G | Jul 17, 2025 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 28, 2026 | Christopher John Kenneyofficer: Chief Medical Officer | Sale · 2 lots | 7,068 | $60.25 | 2 |
| Aug 11, 2026 | Steven Gannondirector | Sale | 10,000 | $64.06 | 1,870 |
| Jun 5, 2026 | Gillian Cannondirector | Sale | 1,190 | $53.14 | 1,455 |
| Jun 5, 2026 | Gary Patoudirector | Sale | 1,322 | $53.14 | 24,896 |
| Mar 13, 2026 | Ian Mortimerdirector, officer: PRESIDENT & CEO | Sale | 7,308 | $55.23 | 19,923 |
| Mar 13, 2026 | Andrea DiFabioofficer: Chief Legal Officer | Sale | 1,342 | $55.23 | 7,301 |
| Mar 13, 2026 | Christopher John Kenneyofficer: Chief Medical Officer | Sale | 1,410 | $55.23 | 7,069 |
| Mar 9, 2026 | Ian Mortimerdirector, officer: PRESIDENT & CEO | Sale · 9 lots | 270,000 | $60.33 | 6,000 |
| Mar 10, 2026 | Ian Mortimerdirector, officer: PRESIDENT & CEO | Sale | 11,269 | $60.11 | 14,731 |
| Mar 10, 2026 | Andrea DiFabioofficer: Chief Legal Officer | Sale | 2,607 | $60.11 | 4,893 |
House and Senate disclosures
Not reported.